Hutchmed
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
25a Vreeland Rd Ste 304, Florham Park, N...Phone Number
(212) 250-9100Website
www.chi-med.comRevenue
$129.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Hutchmed
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capability. As of 2000, we have an in-house scientific team of around 680 professionals, and a pipeline of 10 clinical stage drug candidates in clinical studies around the world. We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes prescription drugs and consumer health products, as well as two of our marketed novel oncology products ELUNATE® (fruquintinib capsules)and SULANDA® (surufatinib capsules) - in China. We are expanding the geographic scope of our commercial operations to include the URead more
Hutchmed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hutchmed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hutchmed had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Hutchmed has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Hutchmed launches new products
Funding: Get notified immidiatlly once Hutchmed has new funding data
Hutchmed, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Hutchmed
Check out if Hutchmed is spiking on competitors!
Earning: See what the market has to say on Hutchmed recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Hutchmed
Compare insights from companies similar to Hutchmed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hutchmed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hutchmed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hutchmed.
Hutchmed Tech Stack
A closer look at the technologies used by Hutchmed
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hutchmed News & Media
Should You Be Adding HUTCHMED (China) (LON:HCM) To Your Watchlist Today?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...HUTCHMED (China) Limited (HCM) Q4 2025 Earnings Call Transcript
HUTCHMED (China) Limited (HCM) Q4 2025 Earnings Call March 5, 2026 8:00 AM ESTCompany ParticipantsDavid Ng - Head of Investor Relations & Capital...Private equity firms among HUTCHMED (China) Limited's (LON:HCM) largest stockholders and were hit after last week's 4.8% price drop
Key Insights HUTCHMED (China)'s significant private equity firms ownership suggests that the key decisions are...HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025 Transcript
HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Deutsche Bank ADR Virtual Investor Conference 2025 November 4, 2025 8:00 AM ESTCompany...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hutchmed
Sign Up For FreeTo access detailed company insights
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a full... Read More
